| Unique ID issued by UMIN | UMIN000062296 |
|---|---|
| Receipt number | R000071240 |
| Scientific Title | Analgesic efficacy of adding vastus intermedius and vastus lateralis nerve blocks after total knee arthroplasty: A randomized controlled trial |
| Date of disclosure of the study information | 2026/07/25 |
| Last modified on | 2026/07/24 14:45:51 |
Analgesic efficacy of adding vastus intermedius and vastus lateralis nerve blocks after total knee arthroplasty: A randomized controlled trial
Analgesic efficacy of adding vastus intermedius and vastus lateralis nerve blocks after total knee arthroplasty: A randomized controlled trial
Analgesic efficacy of adding vastus intermedius and vastus lateralis nerve blocks after total knee arthroplasty: A randomized controlled trial
Analgesic efficacy of adding vastus intermedius and vastus lateralis nerve blocks after total knee arthroplasty: A randomized controlled trial
| Japan |
knee osteoarthritis
| Orthopedics | Anesthesiology | Rehabilitation medicine |
Others
NO
The aim of this study is to test the hypothesis that adding the vastus intermedius (NVI) nerve and the vastus lateralis (NVL) nerve blocks to a femoral triangle block (FTB) combined with an IPACK block improves postoperative pain scores in patients undergoing total knee arthroplasty (TKA).
Efficacy
Postoperative pain Numerical Rating Scale (NRS) scores
Pain NRS score
Pain location
Motor assessment
Opioid consumption
Knee functional assessment
Quality of recovery
Consumption of postoperative additional analgesics
Complications and adverse events
Blinding Assessment
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
No treatment
NO
NO
Institution is not considered as adjustment factor.
YES
Numbered container method
2
Treatment
| Maneuver |
Addition of vastus intermedius and vastus lateralis nerve blocks (5 mL of 0.25% levobupivacaine each)
No additional vastus intermedius and vastus lateralis nerve blocks
| 18 | years-old | <= |
| 85 | years-old | >= |
Male and Female
1. Participants aged between 18 and 85 years
2. Participants were scheduled for primary unilateral TKA for osteoarthritis
3. American Society of Anaesthesiologists Physical Status Classification I-III
4. Body mass index of 18-40 kg/m2
5. Written informed consent is provided
1. Allergy to any drug administered in this study
2. Pre-existing lower limb motor dysfunction
3. Severe hepatic or renal dysfunction
4. Uncontrolled asthma
5. Inability to reliably assess pain
6. Severe peripheral neuropathy
7. Anticipated technical difficulty in performing the nerve blocks
8. Inability or unwillingness to comply with the study protocol
9. Chronic opioid use
74
| 1st name | Takashi |
| Middle name | |
| Last name | Fujino |
Juntendo University School of Medicine
Department of Anesthesiology and Pain Medicine
113-8421
2-1-1 Hongo, Bunkyo-ku, Tokyo, Japan
+81-3-3813-3111
t-fujino@juntendo.ac.jp
| 1st name | Takashi |
| Middle name | |
| Last name | Fujino |
Juntendo University School of Medicine
Department of Anesthesiology and Pain Medicine
113-8421
2-1-1 Hongo, Bunkyo-ku, Tokyo, Japan
+81-3-3813-3111
t-fujino@juntendo.ac.jp
Juntendo University School of Medicine
Juntendo University School of Medicine
Self funding
Research Ethics Committee Faculty Of Medicine, Juntendo University
3-1-1 Hongo, Bunkyo-ku, Tokyo, Japan
+81-3-5802-1584
hongo-rinri@juntendo.ac.jp
NO
順天堂大学医学部附属順天堂医院
| 2026 | Year | 07 | Month | 25 | Day |
Unpublished
Preinitiation
| 2026 | Year | 06 | Month | 07 | Day |
| 2026 | Year | 07 | Month | 13 | Day |
| 2026 | Year | 08 | Month | 12 | Day |
| 2027 | Year | 12 | Month | 31 | Day |
| 2026 | Year | 07 | Month | 22 | Day |
| 2026 | Year | 07 | Month | 24 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071240